Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Charles Swanton

Showing results (151-160 of 439) with videos related to

Pageof 44
Sort By:
Genome Biology|June 13, 2025
Cancer gene identification from RNA variant allelic frequencies using RVdriverJames R M Black, Thomas P Jones, Carlos Martínez-Ruiz, et al.
Lancet (London, England)|August 2, 2021
Misuse of SARS-CoV-2 testing in symptomatic health-care staff in the UK - Authors' replyJames R M Black, Chris Bailey, Joanna Przewrocka, et al.
Cancers|October 14, 2022
Cell-Free DNA-Based Multi-Cancer Early Detection Test in an Asymptomatic Screening Population (NHS-Galleri): Design of a Pragmatic, Prospective Randomised Controlled TrialRichard D Neal, Peter Johnson, Christina A Clarke, et al.
Cell Cycle (Georgetown, Tex.)|December 11, 2008
Concordance of exon array and real-time PCR assessment of gene expression following cancer cell cytotoxic drug exposureAlvin J X Lee, Phillip East, Stuart Pepper, et al.
Cancer Research|June 28, 2014
Chromosomal instability selects gene copy-number variants encoding core regulators of proliferation in ER+ breast cancerDavid Endesfelder, Rebecca Burrell, Nnennaya Kanu, et al.
Breast (Edinburgh, Scotland)|April 5, 2015
New approaches for improving outcomes in breast cancer in EuropeAngelo Di Leo, Giuseppe Curigliano, Véronique Diéras, et al.
Plos One|December 15, 2010
Minimising immunohistochemical false negative ER classification using a complementary 23 gene expression signature of ER statusQiyuan Li, Aron C Eklund, Nicolai Juul, et al.
JCO Precision Oncology|April 16, 2025
Safety and Activity of Fibroblast Growth Factor Receptor Inhibitors in Advanced Malignancies: A Pooled Analysis of Early-Phase Clinical TrialsRafael Grochot, Kroopa Joshi, Antonella Cammarota, et al.
Cancer Discovery|April 3, 2021
Tracking Cancer Evolution through the Disease CourseChris Bailey, James R M Black, James L Reading, et al.
G3 (Bethesda, Md.)|September 18, 2014
The genome of the chicken DT40 bursal lymphoma cell lineJános Molnár, Ádám Póti, Orsolya Pipek, et al.
Pageof 44

Showing results (151-160 of 439) with videos related to

Sort By:
Pageof 44
Genome Biology|June 13, 2025
Cancer gene identification from RNA variant allelic frequencies using RVdriverJames R M Black, Thomas P Jones, Carlos Martínez-Ruiz, et al.
Lancet (London, England)|August 2, 2021
Misuse of SARS-CoV-2 testing in symptomatic health-care staff in the UK - Authors' replyJames R M Black, Chris Bailey, Joanna Przewrocka, et al.
Cancers|October 14, 2022
Cell-Free DNA-Based Multi-Cancer Early Detection Test in an Asymptomatic Screening Population (NHS-Galleri): Design of a Pragmatic, Prospective Randomised Controlled TrialRichard D Neal, Peter Johnson, Christina A Clarke, et al.
Cell Cycle (Georgetown, Tex.)|December 11, 2008
Concordance of exon array and real-time PCR assessment of gene expression following cancer cell cytotoxic drug exposureAlvin J X Lee, Phillip East, Stuart Pepper, et al.
Cancer Research|June 28, 2014
Chromosomal instability selects gene copy-number variants encoding core regulators of proliferation in ER+ breast cancerDavid Endesfelder, Rebecca Burrell, Nnennaya Kanu, et al.
Breast (Edinburgh, Scotland)|April 5, 2015
New approaches for improving outcomes in breast cancer in EuropeAngelo Di Leo, Giuseppe Curigliano, Véronique Diéras, et al.
Plos One|December 15, 2010
Minimising immunohistochemical false negative ER classification using a complementary 23 gene expression signature of ER statusQiyuan Li, Aron C Eklund, Nicolai Juul, et al.
JCO Precision Oncology|April 16, 2025
Safety and Activity of Fibroblast Growth Factor Receptor Inhibitors in Advanced Malignancies: A Pooled Analysis of Early-Phase Clinical TrialsRafael Grochot, Kroopa Joshi, Antonella Cammarota, et al.
Cancer Discovery|April 3, 2021
Tracking Cancer Evolution through the Disease CourseChris Bailey, James R M Black, James L Reading, et al.
G3 (Bethesda, Md.)|September 18, 2014
The genome of the chicken DT40 bursal lymphoma cell lineJános Molnár, Ádám Póti, Orsolya Pipek, et al.
Pageof 44